NEOMYCIN SULFATE-TRIAMCINOLONE ACETONIDE Drug Patent Profile

« Back to Dashboard

When do Neomycin Sulfate-triamcinolone Acetonide patents expire, and what generic alternatives are available?

Neomycin Sulfate-triamcinolone Acetonide is a drug marketed by Fougera and Pharmaderm and is included in four NDAs.

The generic ingredient in NEOMYCIN SULFATE-TRIAMCINOLONE ACETONIDE is neomycin sulfate; triamcinolone acetonide. There is one drug master file entry for this compound. Additional details are available on the neomycin sulfate; triamcinolone acetonide profile page.

Summary for NEOMYCIN SULFATE-TRIAMCINOLONE ACETONIDE

US Patents:	0
Applicants:	2
NDAs:	4
DailyMed Link:	NEOMYCIN SULFATE-TRIAMCINOLONE ACETONIDE at DailyMed

US Patents and Regulatory Information for NEOMYCIN SULFATE-TRIAMCINOLONE ACETONIDE

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Fougera	NEOMYCIN SULFATE-TRIAMCINOLONE ACETONIDE	neomycin sulfate; triamcinolone acetonide	CREAM;TOPICAL	062600-001	Jul 21, 1986		DISCN	No	No
Pharmaderm	NEOMYCIN SULFATE-TRIAMCINOLONE ACETONIDE	neomycin sulfate; triamcinolone acetonide	OINTMENT;TOPICAL	062607-001	May 23, 1986		DISCN	No	No
Pharmaderm	NEOMYCIN SULFATE-TRIAMCINOLONE ACETONIDE	neomycin sulfate; triamcinolone acetonide	CREAM;TOPICAL	062595-001	Jul 21, 1986		DISCN	No	No
Fougera	NEOMYCIN SULFATE-TRIAMCINOLONE ACETONIDE	neomycin sulfate; triamcinolone acetonide	OINTMENT;TOPICAL	062608-001	May 23, 1986		DISCN	No	No